Valuation Mankind Pharma Limited

Equities

Delayed NSE India S.E. Other stock markets 03:53:55 13/03/2026 pm IST			5-day change	1st Jan Change
2,138.90 ^INR	-3.13%		-2.20%	-2.62%

27/02	Mankind Pharma says tax penalty of 10.2 million rupees dropped	RE
16/02	Mankind Pharma says tax penalty of 4.6 million rupees dropped	RE

Data adjusted to current consolidation scope

Fiscal Period: March	2024	2025	2026	2027	2028
Capitalization ¹	9,21,654	10,00,400	9,11,432	-	-
Change	-	8.54%	-8.89%	-	-
Enterprise Value (EV) ¹	8,89,053	10,62,777	9,65,451	9,40,097	9,30,538
Change	-	19.54%	-9.16%	-2.63%	-1.02%
P/E ratio	48.3x	49.3x	48.3x	37.3x	30.3x
PBR	9.84x	6.98x	5.62x	4.88x	4.25x
PEG	1x	15.46x	-6.81x	1.3x	1.3x
Capitalization / Revenue	8.92x	8.2x	6.34x	5.7x	5.13x
EV / Revenue	8.6x	8.71x	6.72x	5.88x	5.24x
EV / EBITDA	35.1x	35.2x	27.2x	22.9x	19.9x
EV / EBIT	41.6x	44.3x	35.7x	29.3x	25x
EV / FCF	48.4x	55.8x	48.4x	37.6x	31.4x
FCF Yield	2.07%	1.79%	2.07%	2.66%	3.18%
Dividend per Share ²	-	-	4.017	6.229	8.117
Rate of return	-	-	0.18%	0.28%	0.37%
EPS ²	47.68	49.2	45.71	59.21	72.79
Distribution rate	-	-	8.79%	10.5%	11.2%
Net sales ¹	1,03,348	1,22,074	1,43,656	1,59,827	1,77,741
EBITDA ¹	25,351	30,179	35,499	41,001	46,759
EBIT ¹	21,368	23,967	27,021	32,113	37,255
Net income ¹	19,129	19,910	18,516	24,353	30,010
Net Debt ¹	-32,600	62,377	54,019	28,665	19,106
Reference price ²	2,300.75	2,424.75	2,207.90	2,207.90	2,207.90
Nbr of stocks (in thousands)	4,00,588	4,12,579	4,12,805	-	-
Announcement Date	15/05/24	21/05/25	-	-	-

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
MANKIND PHARMA LIMITED	48.3x	6.72x	27.2x	0.18%	987.17Cr
ELI LILLY AND COMPANY	28.72x	10.82x	21.74x	0.68%	87TCr
JOHNSON & JOHNSON	25.68x	5.98x	16.28x	2.19%	58TCr
ABBVIE INC.	24.62x	6.7x	13.46x	3.08%	40TCr
ROCHE HOLDING AG	17.19x	4.19x	10.36x	3.16%	32TCr
ASTRAZENECA PLC	24.12x	5.03x	13.93x	1.73%	30TCr
NOVARTIS AG	20.99x	5.66x	13.99x	2.86%	29TCr
MERCK & CO., INC.	27.09x	4.75x	14.85x	2.91%	29TCr
AMGEN INC.	24.74x	6.28x	11.18x	2.73%	20TCr
GILEAD SCIENCES, INC.	20.13x	6.12x	11.08x	2.24%	18TCr
Average	26.16x	6.23x	15.40x	2.18%	34.45TCr
Weighted average by Cap.	24.83x	6.94x	15.73x	2.11%